AlphAIAlphAI — Financial news for AI agents
SEC EDGAROCT 61 min read$ARQQ

Leaver Andrew sold $69K of ARQQ

Leaver Andrew (Chief Executive Officer) sold 2,818 shares of Arqit Quantum Inc. (ARQQ) at $24.47 on 2026-10-02.

Original reporting
SEC EDGAR · Leaver Andrew
Published Oct 6, 2026, 11:42 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 11:47 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$ARQQ
Neutral
high confidence
Mentioned
$ARQQ
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ARQQNeutralLow
01

Why it matters

The disclosed sale is modest and unlikely to move the stock significantly, but it provides transparency for investors.

02

Market read

A small insider sell by the CEO, modestly reducing his holdings; limited trading relevance.

03

What to watch

Potential upcoming financing needs or personal liquidity requirements.

Relevance 3/10Novelty 3/10Timing: today

Background

Form 4 filings disclose insider transactions and are primary sources for such events.

Company-level read

Ticker impact

$ARQQNeutralHigh confidence
Context

CEO Leaver Andrew sold 2,818 shares for $68,969, reducing his stake to 59,082 shares.

Expected impact

likely slight pressure as the market prices in the insider sell.

Evidence & confidence

The sale is small relative to market cap and does not indicate major concerns, but any insider sell can cause modest short-term downside.

Market effects

Sector

No broader sector impact; the sale is company‑specific.

Regional

None.

Global

None.

Counterpoint

What could challenge this read

The sale may be routine and not indicative of future weakness.

Key entities

  • person
    Leaver Andrew

    Chief Executive Officer of Arqit Quantum Inc.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ARQQ insider trading history →

Related articles

JUN 4
$QNTMedAI 9/10

Quantum Computing Shares Sink Ahead Of Blockbuster Quantinuum IPO

Quantinuum (QNT) shares fell Wednesday as the Honeywell-backed firm neared its Nasdaq debut, with pricing set for June 3 and first trading expected June 4. The company plans to sell 26.5 million shares at $53–$55 to raise about $1.46 billion, valuing it at up to $14.3 billion, according to the report. Other quantum stocks also declined.

finance.yahoo.com4 min
OCT 27
$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).

SEC EDGAR1 min